Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Efficacy Study of the Effect of Etanercept in Hemodialysis Patients

This study has been terminated.
(We were unable to recruit sufficient patients within the confines of our budget)
Sponsor:
Collaborators:
Amgen
Dialysis Clinic, Inc.
Information provided by:
Kaysen, George A., M.D., Ph.D.
ClinicalTrials.gov Identifier:
NCT00293202
First received: February 15, 2006
Last updated: April 4, 2012
Last verified: April 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2010
  Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)
No publications provided by Kaysen, George A., M.D., Ph.D.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):